Pexidartinib for the treatment of adult symptomatic patients with tenosynovial giant cell tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pexidartinib for the treatment of adult symptomatic patients with tenosynovial giant cell tumors

Published:2020-06-01 Issue:6 Volume:13 Page:571-576
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Baldi Giacomo Giulio¹,Gronchi Alessandro²^ORCID,Stacchiotti Silvia³

Affiliation:

1. “Sandro Pitigliani” Medical Oncology Department, Hospital of Prato, Prato, Italy

2. Department of Surgery, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy

3. Medical Oncology Unit 2, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2020.1771179

Reference35 articles.

1. Pigmented Villonodular Synovitis

2. Malignant pigmented villonodular synovitis of the temporomandibular joint with lung metastasis: a case report and review of the literature

3. Metastasizing tenosynovial giant cell tumour, diffuse type/pigmented villonodular synovitis

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Selective Imidazopyridine CSF1R Inhibitors;ACS Medicinal Chemistry Letters;2024-04-30

2. Identifying the Reactive Metabolites of Tyrosine Kinase Inhibitor Pexidartinib In Vitro Using LC–MS-Based Metabolomic Approaches;Chemical Research in Toxicology;2023-08-02

3. Pexidartinib hydrochloride exposure induces developmental toxicity and immunotoxicity in zebrafish embryos via activation of Wnt signaling;Fish & Shellfish Immunology;2023-07

4. Molecular testing of soft tissue tumors;Diagnostic Cytopathology;2022-07-09

5. Pexidartinib in the Management of Advanced Tenosynovial Giant Cell Tumor: Focus on Patient Selection and Special Considerations;OncoTargets and Therapy;2022-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3